Ex parte UETANI et al. - Page 4




          Appeal No. 1997-2593                                                        
          Application No. 08/160,290                                                  


          novalaks); and compatible residual coating solvents such as (-              
          butyrolactone and diacetone alcohol.  See the respective                    
          disclosures of Liu at column 4, lines 3-12; column 4, lines                 
          12-21; and column 5, lines 3-7.  Significantly, as emphasized               
          by the examiner in his answer, Liu further exemplifies                      
          photosensitive coating compositions comprised of solvent blend              
          mixtures including diacetone alcohol and (-butyrolactone in                 
          weight ratio of 42:58.  See the "Black" formulation described               
          at column 5, lines 25-42 of Liu.                                            
               Apparently, based on the disclosure of the "black color                
          formulation" described at column 5, lines 25-42 of Liu,                     
          appealed claims 1, 7, 10, and 23 were rejected as                           
          "anticipated" by Liu.  See the answer at page 4.  However,                  
          Liu’s specific "black color formulation" utilizes a polyvinyl               
          acetal/alcohol/acetate resin, not a novolak resin, as required              
          by the appealed claims, and accordingly, appellants correctly               
          point out that Liu "fails to disclose any specific example of               
          an embodiment falling within the scope of the claims of the                 
          present application" (brief, page 9).   Moreover, even the                  
          examiner acknowledges (answer, page 4) that "[a] clear-cut 35               
          U.S.C. § 102 rejection may not apply" because excessive                     
                                          4                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007